Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	adherens junction	EZR KLHL24 SYNM RDX HMCN1 TLN1 LRRC7 LYN NEXN	4.67e-05	212	164	9	GO:0005912
GeneOntologyCellularComponent	cell-cell junction	EZR KLHL24 SYNM OBSCN RDX LCK FNDC1 HMCN1 PTPRJ TLN1 TLN2 LRRC7 LYN NEXN	2.42e-04	591	164	14	GO:0005911
MousePheno	cardiac fibrosis	SYNM OBSCN LAMA4 CMYA5 RYR2 TXNDC5 ASXL3 RERE NEXN	1.07e-05	151	129	9	MP:0003141
Domain	Cmyb_C	MYB MYBL1 MYBL2	6.29e-07	3	161	3	PF09316
Domain	C-myb_C	MYB MYBL1 MYBL2	6.29e-07	3	161	3	IPR015395
Domain	FN3	FNDC3B OBSCN NCAM2 CMYA5 FNDC1 NEO1 CSF3R PTPRJ ATF7IP RIMBP2 CNTN2	1.26e-06	199	161	11	PS50853
Domain	fn3	FNDC3B OBSCN NCAM2 CMYA5 FNDC1 NEO1 CSF3R PTPRJ RIMBP2 CNTN2	1.44e-06	162	161	10	PF00041
Domain	FN3_dom	FNDC3B OBSCN NCAM2 CMYA5 FNDC1 NEO1 CSF3R PTPRJ ATF7IP RIMBP2 CNTN2	2.04e-06	209	161	11	IPR003961
Domain	FN3	FNDC3B OBSCN NCAM2 CMYA5 FNDC1 NEO1 CSF3R PTPRJ RIMBP2 CNTN2	4.75e-06	185	161	10	SM00060
Domain	FERM_N	EZR RDX PTPN13 TLN1 TLN2	8.73e-06	33	161	5	IPR018979
Domain	FERM_N	EZR RDX PTPN13 TLN1 TLN2	8.73e-06	33	161	5	PF09379
Domain	FERM_M	EZR RDX PTPN13 TLN1 TLN2	4.61e-05	46	161	5	PF00373
Domain	FERM_CS	EZR RDX TLN1 TLN2	4.94e-05	24	161	4	IPR019747
Domain	HTH_MYB	MYB MYBL1 MYBL2	5.08e-05	9	161	3	PS51294
Domain	Myb_dom	MYB MYBL1 MYBL2	5.08e-05	9	161	3	IPR017930
Domain	-	EZR RDX PTPN13 TLN1 TLN2	6.28e-05	49	161	5	1.20.80.10
Domain	FERM_central	EZR RDX PTPN13 TLN1 TLN2	6.28e-05	49	161	5	IPR019748
Domain	FERM_domain	EZR RDX PTPN13 TLN1 TLN2	6.28e-05	49	161	5	IPR000299
Domain	FERM/acyl-CoA-bd_prot_3-hlx	EZR RDX PTPN13 TLN1 TLN2	6.93e-05	50	161	5	IPR014352
Domain	FERM_1	EZR RDX PTPN13 TLN1 TLN2	6.93e-05	50	161	5	PS00660
Domain	FERM_2	EZR RDX PTPN13 TLN1 TLN2	6.93e-05	50	161	5	PS00661
Domain	FERM_3	EZR RDX PTPN13 TLN1 TLN2	6.93e-05	50	161	5	PS50057
Domain	Band_41_domain	EZR RDX PTPN13 TLN1 TLN2	6.93e-05	50	161	5	IPR019749
Domain	B41	EZR RDX PTPN13 TLN1 TLN2	6.93e-05	50	161	5	SM00295
Domain	-	TLN1 TLN2	7.39e-05	2	161	2	1.20.1420.10
Domain	VBS	TLN1 TLN2	7.39e-05	2	161	2	PF08913
Domain	Vinculin-bd_dom	TLN1 TLN2	7.39e-05	2	161	2	IPR015009
Domain	Talin_cent	TLN1 TLN2	7.39e-05	2	161	2	IPR015224
Domain	Tscrpt_reg_Wos2-domain	MYB MYBL1	7.39e-05	2	161	2	IPR012642
Domain	Talin_middle	TLN1 TLN2	7.39e-05	2	161	2	PF09141
Domain	LMSTEN	MYB MYBL1	7.39e-05	2	161	2	PF07988
Domain	-	CLGN CANX	2.20e-04	3	161	2	2.10.250.10
Domain	Talin-1	TLN1 TLN2	2.20e-04	3	161	2	IPR015710
Domain	CALRETICULIN_REPEAT	CLGN CANX	2.20e-04	3	161	2	PS00805
Domain	Myb_DNA-binding	RERE MYB MYBL1 MYBL2	2.26e-04	35	161	4	PF00249
Domain	MYB_LIKE	RERE MYB MYBL1 MYBL2	3.12e-04	38	161	4	PS50090
Domain	PH_dom-like	EZR OBSCN RDX LYST PTPN13 ARHGEF10 PLEKHG3 TLN1 TLN2 PLCH1 FGD6 SNTB1	3.32e-04	426	161	12	IPR011993
Domain	ERM_C_dom	EZR RDX	4.38e-04	4	161	2	IPR011259
Domain	ILWEQ_dom	TLN1 TLN2	4.38e-04	4	161	2	IPR002558
Domain	Neural_cell_adh	NCAM2 HMCN1	4.38e-04	4	161	2	IPR009138
Domain	ILWEQ	TLN1 TLN2	4.38e-04	4	161	2	SM00307
Domain	FERM_f0	TLN1 TLN2	4.38e-04	4	161	2	PF16511
Domain	ILWEQ	TLN1 TLN2	4.38e-04	4	161	2	PD011820
Domain	-	TLN1 TLN2	4.38e-04	4	161	2	1.20.1410.10
Domain	I_LWEQ	TLN1 TLN2	4.38e-04	4	161	2	PF01608
Domain	Calret/calnex	CLGN CANX	4.38e-04	4	161	2	IPR001580
Domain	I_LWEQ	TLN1 TLN2	4.38e-04	4	161	2	PS50945
Domain	CALRETICULIN_1	CLGN CANX	4.38e-04	4	161	2	PS00803
Domain	CALRETICULIN_2	CLGN CANX	4.38e-04	4	161	2	PS00804
Domain	Calret/calnex_CS	CLGN CANX	4.38e-04	4	161	2	IPR018124
Domain	FERM_f0	TLN1 TLN2	4.38e-04	4	161	2	IPR032425
Domain	ERM	EZR RDX	4.38e-04	4	161	2	PF00769
Domain	Calreticulin	CLGN CANX	4.38e-04	4	161	2	PF00262
Domain	ERM	EZR RDX	4.38e-04	4	161	2	IPR011174
Domain	SH3_domain	OBSCN LCK UBASH3A SH3TC1 MACF1 RIMBP2 LYN ZNF582	6.56e-04	220	161	8	IPR001452
Domain	Calreticulin/calnexin_P_dom	CLGN CANX	7.26e-04	5	161	2	IPR009033
Domain	SANT	RERE MYB MYBL1 MYBL2	9.00e-04	50	161	4	SM00717
Domain	SANT/Myb	RERE MYB MYBL1 MYBL2	1.04e-03	52	161	4	IPR001005
Domain	KRAB	ZNF140 ZNF658 ZNF184 ZFP69 ZNF461 ZNF394 ZNF565 ZNF582 ZNF583 ZFP82	1.11e-03	358	161	10	PS50805
Domain	KRAB	ZNF140 ZNF658 ZNF184 ZFP69 ZNF461 ZNF394 ZNF565 ZNF582 ZNF583 ZFP82	1.11e-03	358	161	10	PF01352
Domain	Ig_I-set	OBSCN NCAM2 IGSF10 NEO1 HMCN1 NEXN CNTN2	1.32e-03	190	161	7	IPR013098
Domain	I-set	OBSCN NCAM2 IGSF10 NEO1 HMCN1 NEXN CNTN2	1.32e-03	190	161	7	PF07679
Domain	ZF_PHD_2	NSD3 PHF2 KMT2C ASXL3 KDM2B	1.39e-03	95	161	5	PS50016
Domain	KRAB	ZNF140 ZNF658 ZNF184 ZFP69 ZNF461 ZNF394 ZNF565 ZNF582 ZNF583 ZFP82	1.39e-03	369	161	10	SM00349
Domain	FERM_C	EZR RDX PTPN13	1.41e-03	26	161	3	PF09380
Domain	KRAB	ZNF140 ZNF658 ZNF184 ZFP69 ZNF461 ZNF394 ZNF565 ZNF582 ZNF583 ZFP82	1.42e-03	370	161	10	IPR001909
Domain	ZF_PHD_1	NSD3 PHF2 KMT2C ASXL3 KDM2B	1.45e-03	96	161	5	PS01359
Domain	Vinculin/catenin	TLN1 TLN2	1.51e-03	7	161	2	IPR006077
Domain	Moesin_tail	EZR RDX	1.51e-03	7	161	2	IPR008954
Domain	SCAN_BOX	ZNF232 ZFP69 ZSCAN29 ZNF394	1.57e-03	58	161	4	PS50804
Domain	FERM_PH-like_C	EZR RDX PTPN13	1.58e-03	27	161	3	IPR018980
Domain	FERM_C	EZR RDX PTPN13	1.58e-03	27	161	3	SM01196
Domain	-	FNDC3B OBSCN NCAM2 CMYA5 IGSF10 FNDC1 NEO1 HMCN1 CSF3R PTPRJ ATF7IP RIMBP2 NEXN CNTN2	1.83e-03	663	161	14	2.60.40.10
Domain	-	EZR OBSCN RDX PTPN13 PLEKHG3 TLN1 TLN2 PLCH1 FGD6 SNTB1	2.13e-03	391	161	10	2.30.29.30
Domain	-	ZNF140 ZNF658 ZNF184 ZNF232 ZFP69 ZNF461 ZSCAN29 ZNF394 ZNF35 ZFHX4 ZNF565 ZNF582 ZNF583 ZFP82	2.28e-03	679	161	14	3.30.160.60
Domain	SH3	OBSCN LCK UBASH3A SH3TC1 MACF1 RIMBP2 LYN	2.73e-03	216	161	7	PS50002
Domain	zf-C2H2	ZNF140 ZNF658 ZNF184 ZNF232 ZFP69 ZNF461 ZSCAN29 ZNF394 ZNF35 ZFHX4 ZNF565 ZNF582 ZNF583 ZFP82	2.74e-03	693	161	14	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF140 ZNF658 ZNF184 ZNF232 ZFP69 ZNF461 ZSCAN29 ZNF394 ZNF35 ZFHX4 ZNF565 ZNF582 ZNF583 ZFP82	2.77e-03	694	161	14	IPR013087
Domain	RhoGEF	OBSCN ARHGEF10 PLEKHG3 FGD6	2.82e-03	68	161	4	SM00325
Domain	RhoGEF	OBSCN ARHGEF10 PLEKHG3 FGD6	3.14e-03	70	161	4	PF00621
Domain	DH_2	OBSCN ARHGEF10 PLEKHG3 FGD6	3.14e-03	70	161	4	PS50010
Domain	Ig-like_fold	FNDC3B OBSCN NCAM2 CMYA5 IGSF10 FNDC1 NEO1 HMCN1 CSF3R PTPRJ ATF7IP RIMBP2 NEXN CNTN2	3.23e-03	706	161	14	IPR013783
Domain	-	OBSCN ARHGEF10 PLEKHG3 FGD6	3.30e-03	71	161	4	1.20.900.10
Domain	DH-domain	OBSCN ARHGEF10 PLEKHG3 FGD6	3.30e-03	71	161	4	IPR000219
Domain	Znf_C2H2-like	ZNF140 ZNF658 ZNF184 ZNF318 ZNF232 ZFP69 ZNF461 ZSCAN29 ZNF394 ZNF35 ZFHX4 ZNF565 ZNF582 ZNF583 ZFP82	3.75e-03	796	161	15	IPR015880
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	PUM2 TNRC6C PHF2 KMT2C ARHGEF10 TLN1 MACF1 TLN2 OGA UNC80 SMG6	1.44e-08	225	168	11	12168954
Pubmed	The myb gene family in cell growth, differentiation and apoptosis.	MYB MYBL1 MYBL2	1.11e-07	3	168	3	10378697
Pubmed	Temporal patterns of A-myb and B-myb gene expression during testis development.	MYB MYBL1 MYBL2	4.41e-07	4	168	3	8808690
Pubmed	Human transcription factor protein interaction networks.	CANX PUM2 ZNF318 TNRC6C WASHC2A PHF2 KMT2C LIG3 ZFHX4 NSA2 SAMD11 ATF7IP KDM2B SIX5 PDS5A RERE CABIN1 USP27X MRPL24 SNTB1 YTHDF3 MYB MYBL2	4.42e-07	1429	168	23	35140242
Pubmed	Follow-up analysis of genome-wide association data identifies novel loci for type 1 diabetes.	BACH2 UBASH3A RASGRP1	1.10e-06	5	168	3	18840781
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	TLK2 EZR MAP1A RDX ZNF318 PRDX2 RMI1 LIG3 TLN1 PDS5A YTHDF3 AHNAK2	1.90e-06	444	168	12	34795231
Pubmed	The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3.	MYB MYBL1 MYBL2	2.19e-06	6	168	3	16055500
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MAP1A U2SURP PARG PUM2 RDX ZNF318 PRDX2 ADAR CBS LIG3 PTPN13 ATF7IP TLN1 MACF1 OGA PLRG1 AHNAK2	3.17e-06	934	168	17	33916271
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PUM2 TNRC6C WASHC2A SEMA6D TENM3 TLN1 NAV3 MACF1 RIMBP2 LRRC7 RERE	5.15e-06	407	168	11	12693553
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	EZR MAP1A CANX U2SURP HECTD4 PRDX2 ADAR PHC2 NSD3 ARG1 ZSCAN29 PHF2 LIG3 TBC1D10B PTPN13 MACF1 PDS5A PLRG1	5.56e-06	1082	168	18	38697112
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	EZR FNDC3B NRIP1 OBSCN LAMA4 RDX CMYA5 NEO1 BNIP2 TLN1 MACF1 HOOK2	6.00e-06	497	168	12	23414517
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	NRIP1 MAP1A BACH2 CANX ZNF318 WASHC2A RMI1 ATF7IP KDM2B MACF1 PLRG1 YTHDF3 MYBL2	6.29e-06	588	168	13	38580884
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	CANX U2SURP ADAR ARG1 RMI1 LIG3 FBH1 PDS5A PLRG1 YTHDF3	6.71e-06	340	168	10	24332808
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	CRYBG2 HECTD4 OBSCN EXTL3 TNRC6C WASHC2A LYST PHC2 NSD3 RHPN1 KMT2C SH3TC1 TLN1 TLN2 CABIN1 AHNAK2 MYBL2 SMG6	7.40e-06	1105	168	18	35748872
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RAD52 NRIP1 POLR1A HECTD4 OBSCN NCAM2 IQCN TNRC6C ZNF461 PHF2 KMT2C PTPN13 THRB PTPRJ SH3TC1 PLEKHG3 MACF1 LRRC7 HOOK2 RERE SMG6	1.12e-05	1489	168	21	28611215
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	SYNM U2SURP ARHGEF10 TLN2 RIMBP2 CABIN1	1.19e-05	104	168	6	9205841
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	EZR NRIP1 SYNM HECTD4 RDX NCAM2 EXTL3 CMYA5 UBASH3A CBS PTPN13 FBH1 ARHGEF10 NAV3 MACF1 TLN2 ZNF565 CABIN1 ZNF583	1.58e-05	1285	168	19	35914814
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	EZR POLR1A CANX U2SURP PBK RDX PRDX2 ADAR LIG3 TBC1D10B TLN1 MACF1 TLN2 LRRC7 YTHDF3	1.70e-05	847	168	15	35235311
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TLK2 EZR CANX HECTD4 RDX GRIK3 ZNF318 PRDX2 ZNF394 ATF7IP MACF1 TLN2 RIMBP2 LRRC7 CABIN1 SMG6	1.92e-05	963	168	16	28671696
Pubmed	Hyperoxidized peroxiredoxin 2 interacts with the protein disulfide- isomerase ERp46.	PRDX2 TXNDC5	2.32e-05	2	168	2	23713588
Pubmed	Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases.	MYB MYBL1	2.32e-05	2	168	2	36074655
Pubmed	Molecular cloning and sequencing of calnexin-t. An abundant male germ cell-specific calcium-binding protein of the endoplasmic reticulum.	CLGN CANX	2.32e-05	2	168	2	8188695
Pubmed	The sodium leak channel, NALCN, in health and disease.	NALCN UNC80	2.32e-05	2	168	2	24904279
Pubmed	Perspectives for Ezrin and Radixin in Astrocytes: Kinases, Functions and Pathology.	EZR RDX	2.32e-05	2	168	2	31382374
Pubmed	Association between GABA(A) receptor subunit polymorphisms and autism spectrum disorder (ASD).	GABRG2 GABRA4	2.32e-05	2	168	2	26239769
Pubmed	DNA binding and transactivation activity of A-myb, a c-myb-related gene.	MYB MYBL1	2.32e-05	2	168	2	7987850
Pubmed	Spatial coupling of JNK activation to the B cell antigen receptor by tyrosine-phosphorylated ezrin.	EZR LYN	2.32e-05	2	168	2	23338238
Pubmed	Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.	MYB MYBL1	2.32e-05	2	168	2	31563982
Pubmed	Expression of mouse c-myb during embryonic development.	MYB MYBL1	2.32e-05	2	168	2	8570177
Pubmed	UNC80 mutation causes a syndrome of hypotonia, severe intellectual disability, dyskinesia and dysmorphism, similar to that caused by mutations in its interacting cation channel NALCN.	NALCN UNC80	2.32e-05	2	168	2	26545877
Pubmed	Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.	PTPN13 PTPRJ	2.32e-05	2	168	2	19672627
Pubmed	A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration.	MYB MYBL1	2.32e-05	2	168	2	31595312
Pubmed	Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing.	MYB MYBL1	2.32e-05	2	168	2	31028361
Pubmed	Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.	TLN1 TLN2	2.32e-05	2	168	2	26822056
Pubmed	Extracellular rigidity sensing by talin isoform-specific mechanical linkages.	TLN1 TLN2	2.32e-05	2	168	2	26523364
Pubmed	MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts.	MYB MYBL1	2.32e-05	2	168	2	29410490
Pubmed	Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements.	MYB MYBL1	2.32e-05	2	168	2	38368814
Pubmed	Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop.	MYCN MYBL2	2.32e-05	2	168	2	21304178
Pubmed	Emerging role for ERM proteins in cell adhesion and migration.	EZR RDX	2.32e-05	2	168	2	21343695
Pubmed	Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3.	EZR PTP4A3	2.32e-05	2	168	2	18078820
Pubmed	Peptide neurotransmitters activate a cation channel complex of NALCN and UNC-80.	NALCN UNC80	2.32e-05	2	168	2	19092807
Pubmed	Characterization and cell cycle-regulated expression of mouse B-myb.	MYB MYBL2	2.32e-05	2	168	2	1501895
Pubmed	New isoform-specific monoclonal antibodies reveal different sub-cellular localisations for talin1 and talin2.	TLN1 TLN2	2.32e-05	2	168	2	22306379
Pubmed	Identification of a repeated domain within mammalian alpha-synemin that interacts directly with talin.	SYNM TLN1	2.32e-05	2	168	2	18342854
Pubmed	Arrest of spermatogenesis and defective breast development in mice lacking A-myb.	MYB MYBL1	2.32e-05	2	168	2	9109487
Pubmed	Expression of B-Myb during mouse embryogenesis.	MYB MYBL2	2.32e-05	2	168	2	8649849
Pubmed	Radixin is a novel member of the band 4.1 family.	EZR RDX	2.32e-05	2	168	2	1955455
Pubmed	Mapping of ezrin dimerization using yeast two-hybrid screening.	EZR RDX	2.32e-05	2	168	2	9501018
Pubmed	Isolation of human cDNA clones of myb-related genes, A-myb and B-myb.	MYBL1 MYBL2	2.32e-05	2	168	2	3060855
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	MYCN NRIP1 POLR1A ZNF184 NR4A3 ZNF232 PHF2 THRB ZNF35 KDM2B RERE PLRG1 ZFP82 MYB MYBL2	2.54e-05	877	168	15	20211142
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TLK2 MYCN PARG PUM2 ZNF318 IQCN AKT1S1 PHC2 TBC1D10B KDM2B TLN2 RERE OGA MYBL2	2.60e-05	774	168	14	15302935
Pubmed	Genomic analysis of mouse retinal development.	MYCN ZNF184 PBK PRDX2 WASHC2A ADAR PHC2 RHPN1 PTP4A3 TXNDC5 ZFHX4 NAV3 PLCH1 OGA MYB TPH1	3.25e-05	1006	168	16	15226823
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	MYCN COL11A1 CANX ZNF318 PRDX2 CR2 CBS NSD3 ARG1 KMT2C TXNDC5 NSA2 FGD6	3.31e-05	689	168	13	36543142
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	NRIP1 MAP1A SYNM U2SURP PBK ZNF318 ARG1	3.34e-05	184	168	7	32908313
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	TLK2 FNDC3B POLR1A MAP1A PUM2 WASHC2A ADAR PTPN13 TLN1 MACF1 PLRG1 YTHDF3 AHNAK2	5.49e-05	724	168	13	36232890
Pubmed	Novel RFLPs at protooncogene and cancer-related gene loci on mouse chromosomes.	MYCN LCK MYB	5.92e-05	16	168	3	8095010
Pubmed	Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions.	TLN1 TLN2	6.94e-05	3	168	2	12422220
Pubmed	The ezrin-like family of tyrosine kinase substrates: receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation.	EZR RDX	6.94e-05	3	168	2	8479753
Pubmed	Cutting Edge: Deletion of Ezrin in B Cells of Lyn-Deficient Mice Downregulates Lupus Pathology.	EZR LYN	6.94e-05	3	168	2	30021765
Pubmed	Mutations in UNC80, Encoding Part of the UNC79-UNC80-NALCN Channel Complex, Cause Autosomal-Recessive Severe Infantile Encephalopathy.	NALCN UNC80	6.94e-05	3	168	2	26708753
Pubmed	Characterization of lens fiber cell triton insoluble fraction reveals ERM (ezrin, radixin, moesin) proteins as major cytoskeletal-associated proteins.	EZR RDX	6.94e-05	3	168	2	18261459
Pubmed	Ezrin, radixin, and moesin are phosphorylated in response to 2-methoxyestradiol and modulate endothelial hyperpermeability.	EZR RDX	6.94e-05	3	168	2	21659656
Pubmed	Expression, localization, and binding activity of the ezrin/radixin/moesin proteins in the mouse testis.	EZR RDX	6.94e-05	3	168	2	19064715
Pubmed	Regulation of ErbB2 localization and function in breast cancer cells by ERM proteins.	EZR RDX	6.94e-05	3	168	2	27029001
Pubmed	Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement.	EZR RDX	6.94e-05	3	168	2	21864676
Pubmed	Differential expression of ezrin/radixin/moesin (ERM) and ERM-associated adhesion molecules in the blastocyst and uterus suggests their functions during implantation.	EZR RDX	6.94e-05	3	168	2	14613898
Pubmed	Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells.	PTPRJ LYN	6.94e-05	3	168	2	27889108
Pubmed	Inhibition of cell adhesion by phosphorylated Ezrin/Radixin/Moesin.	EZR RDX	6.94e-05	3	168	2	26555866
Pubmed	Genetic variants in components of the NALCN-UNC80-UNC79 ion channel complex cause a broad clinical phenotype (NALCN channelopathies).	NALCN UNC80	6.94e-05	3	168	2	30167850
Pubmed	CMYA5 establishes cardiac dyad architecture and positioning.	CMYA5 RYR2	6.94e-05	3	168	2	35449169
Pubmed	Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection.	EZR RDX	6.94e-05	3	168	2	23703860
Pubmed	Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation.	EZR RDX	6.94e-05	3	168	2	16889625
Pubmed	Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells.	EZR RDX	6.94e-05	3	168	2	21837648
Pubmed	Ezrin and moesin function together to promote T cell activation.	EZR RDX	6.94e-05	3	168	2	19124745
Pubmed	Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases.	CSF3R LYN	6.94e-05	3	168	2	8197119
Pubmed	The Src-like tyrosine kinase Hck is activated by granulocyte colony-stimulating factor (G-CSF) and docks to the activated G-CSF receptor.	LCK CSF3R	6.94e-05	3	168	2	9790917
Pubmed	Activation of Ras requires the ERM-dependent link of actin to the plasma membrane.	EZR RDX	6.94e-05	3	168	2	22132106
Pubmed	Ezrin and radixin both regulate the apical membrane localization of ABCC2 (MRP2) in human intestinal epithelial Caco-2 cells.	EZR RDX	6.94e-05	3	168	2	17825285
Pubmed	Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells.	TLN1 TLN2	6.94e-05	3	168	2	18792400
Pubmed	MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.	MYB MYBL1	6.94e-05	3	168	2	29149504
Pubmed	Arginylation-dependent regulation of a proteolytic product of talin is essential for cell-cell adhesion.	TLN1 TLN2	6.94e-05	3	168	2	22665520
Pubmed	Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma.	MYCN ARG1	6.94e-05	3	168	2	25437558
Pubmed	Ezrin-radixin-moesin family proteins are involved in parvovirus replication and spreading.	EZR RDX	6.94e-05	3	168	2	19321616
Pubmed	Deciphering brain-specific transcriptomic expression of Ezr, Rad and Msn genes in the development of Mus musculus.	EZR RDX	6.94e-05	3	168	2	29906485
Pubmed	An essential role for talin during alpha(M)beta(2)-mediated phagocytosis.	TLN1 TLN2	6.94e-05	3	168	2	17202407
Pubmed	Substrate recognition by the Lyn protein-tyrosine kinase. NMR structure of the immunoreceptor tyrosine-based activation motif signaling region of the B cell antigen receptor.	LCK LYN	6.94e-05	3	168	2	10748115
Pubmed	The prosequence of human lactase-phlorizin hydrolase modulates the folding of the mature enzyme.	CANX LCT	6.94e-05	3	168	2	11751874
Pubmed	Extracellular calcium controls background current and neuronal excitability via an UNC79-UNC80-NALCN cation channel complex.	NALCN UNC80	6.94e-05	3	168	2	21040849
Pubmed	Intellectual disability-associated UNC80 mutations reveal inter-subunit interaction and dendritic function of the NALCN channel complex.	NALCN UNC80	6.94e-05	3	168	2	32620897
Pubmed	Activation of PKC induces leukocyte adhesion by the dephosphorylation of ERM.	EZR RDX	6.94e-05	3	168	2	31843195
Pubmed	Radixin regulates synaptic GABAA receptor density and is essential for reversal learning and short-term memory.	GABRG2 RDX	6.94e-05	3	168	2	25891999
Pubmed	Increased phosphorylation of ezrin/radixin/moesin proteins contributes to proliferation of rheumatoid fibroblast-like synoviocytes.	EZR RDX	6.94e-05	3	168	2	21278069
Pubmed	Mechanotransduction in talin through the interaction of the R8 domain with DLC1.	TLN1 TLN2	6.94e-05	3	168	2	30028837
Pubmed	New insights into the genetic basis of premature ovarian insufficiency: Novel causative variants and candidate genes revealed by genomic sequencing.	NRIP1 MACF1	6.94e-05	3	168	2	33036707
Pubmed	Vinculin and talin: focus on the myocardium.	TLN1 TLN2	6.94e-05	3	168	2	19952892
Pubmed	Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import.	EZR RDX	6.94e-05	3	168	2	15149851
Pubmed	ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells.	EZR RDX	6.94e-05	3	168	2	21352885
Pubmed	Talin depletion reveals independence of initial cell spreading from integrin activation and traction.	TLN1 TLN2	6.94e-05	3	168	2	19160486
Pubmed	A gene family consisting of ezrin, radixin and moesin. Its specific localization at actin filament/plasma membrane association sites.	EZR RDX	6.94e-05	3	168	2	1429901
Pubmed	ERM Proteins at the Crossroad of Leukocyte Polarization, Migration and Intercellular Adhesion.	EZR RDX	6.94e-05	3	168	2	32098334
Cytoband	15q22.3-q23	BBS4 NEO1	7.95e-05	4	168	2	15q22.3-q23
GeneFamily	Fibronectin type III domain containing	FNDC3B OBSCN NCAM2 CMYA5 FNDC1 NEO1 CSF3R PTPRJ ATF7IP CNTN2	6.31e-08	160	113	10	555
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	EZR RDX PTPN13 TLN1 TLN2	1.48e-05	50	113	5	1293
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	OBSCN NCAM2 IGSF10 NEO1 HMCN1 NEXN CNTN2	6.83e-05	161	113	7	593
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF140 ZNF658 ZNF184 ZNF318 ZNF232 ZFP69 ZNF461 ZSCAN29 ZNF394 ZNF35 ZNF565 ZNF582 ZNF583 ZFP82	1.54e-04	718	113	14	28
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	RERE MYB MYBL1 MYBL2	3.35e-04	53	113	4	532
GeneFamily	Zinc fingers MYND-type\|A-kinase anchoring proteins	EZR SYNM CMYA5	7.72e-04	29	113	3	396
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	OBSCN ARHGEF10 PLEKHG3 FGD6	7.74e-04	66	113	4	722
GeneFamily	PHD finger proteins	NSD3 PHF2 KMT2C KDM2B	2.45e-03	90	113	4	88
GeneFamily	PDZ domain containing	RHPN1 PTPN13 LRRC7 SNTB1 AHNAK2	2.66e-03	152	113	5	1220
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	GABRG2 COL11A1 BACH2 SLC24A3 GRIK3 ZNF318 TNRC6C ZBED10P LYST RYR2 ATL1 SEMA6D ZFHX4 NALCN SAMD11 ASXL3 NAV3 KDM2B TLN2 RIMBP2 LRRC7 AHNAK2	2.51e-06	1106	168	22	M39071
Coexpression	MURARO_PANCREAS_BETA_CELL	CLGN PNMA1 MAP1A SYNM NEXMIF DTX3 CANX U2SURP HECTD4 ZNF318 LYST PHC2 KMT2C FRA10AC1 RASGRP1 NEO1 SEMA6D PTPRJ RERE UNC80	3.02e-06	946	168	20	M39169
Coexpression	GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP	EZR NRIP1 BACH2 NR4A3 UBASH3A LYST F8 ARHGEF10 RELT	6.09e-06	200	168	9	M9205
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	DENND2A POLR1A MAP1A NEXMIF SLC24A3 GRIK3 HMGCS2 RYR2 IGSF10 NEO1 PTPN13 SEMA6D HMCN1 ZFHX4 TENM3 CLYBL ASXL3 NEXN GABRA4	1.34e-05	797	164	19	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000	NEXMIF ETFDH HMGCS2 RYR2 RASGRP1 NEO1 ZFHX4 CLYBL ATF7IP GABRA4	4.63e-05	268	164	10	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	NEXMIF SLC24A3 GRIK3 HMGCS2 RYR2 IGSF10 RASGRP1 NEO1 PTPN13 SEMA6D HMCN1 ZFHX4 TENM3 ATF7IP ASXL3 NEXN GABRA4	6.19e-05	740	164	17	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	alpha beta T cells, T.DP69+.Th, 4+ 8+ TCRlo/int 69+, Thymus, avg-3	NR4A3 LCK UBASH3A RASGRP1 MYB	7.83e-05	57	164	5	GSM399394_100
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#1_top-relative-expression-ranked_500	NEXMIF ZNF318 HMGCS2 RYR2 KMT2C RASGRP1 MYBL1	8.32e-05	134	164	7	gudmap_developingGonad_e18.5_ovary_500_k1
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C COL11A1 OBSCN NCAM2 GRIK3 RYR2 HMCN1 ZFHX4 ASXL3 NAV3 TLN2 PLCH1 UNC80 CNTN2	1.20e-14	184	168	14	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C COL11A1 OBSCN NCAM2 GRIK3 RYR2 HMCN1 ZFHX4 ASXL3 NAV3 TLN2 PLCH1 UNC80 CNTN2	1.20e-14	184	168	14	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE1C COL11A1 OBSCN NCAM2 GRIK3 RYR2 HMCN1 ZFHX4 ASXL3 NAV3 TLN2 PLCH1 UNC80 CNTN2	1.20e-14	184	168	14	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	RV\|World / Chamber and Cluster_Paper	KLHL24 PDE1C ETFDH OBSCN LAMA4 CMYA5 THRB TLN2 HOOK2 NEXN	1.88e-09	181	168	10	bbe1e6e59d8889bd37d6e8303116cbdcafca7236
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	DENND2A COL11A1 LAMA4 NCAM2 RYR2 FNDC1 HMCN1 TENM3 NALCN NAV3	3.67e-09	194	168	10	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PARG ZNF184 CMYA5 LYST RYR2 IGSF10 HMCN1 ATF7IP MACF1	2.42e-08	176	168	9	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	DENND2A LAMA4 NCAM2 RYR2 HMCN1 TENM3 NAV3 MACF1 NEXN	4.09e-08	187	168	9	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	LPS-IL1RA-Lymphocytic_NKT-T_cells-iNKT-MAIT\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CRYBG2 COL11A1 LCK UBASH3A RASGRP1 TBC1D10B MYB TPH1	4.47e-08	134	168	8	92981dc68c1b3cdc53f9cf83386c47f0c6c98ae7
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A LAMA4 NCAM2 RYR2 HMCN1 TENM3 NAV3 MACF1 NEXN	4.90e-08	191	168	9	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A LAMA4 NCAM2 RYR2 HMCN1 TENM3 NAV3 MACF1 NEXN	5.12e-08	192	168	9	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 HECTD4 LCK LYST PHF2 KMT2C RASGRP1 OGA MYB	5.36e-08	193	168	9	a6a864644e1b80b7417ea0a27281e79068a3fd3d
ToppCell	facs-Thymus-nan-3m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 PUM2 LCK LYST KMT2C RASGRP1 ATF7IP OGA MYB	5.60e-08	194	168	9	f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCell	facs-Thymus-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 PUM2 LCK LYST KMT2C RASGRP1 ATF7IP OGA MYB	5.60e-08	194	168	9	cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCell	facs-Thymus-nan-3m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NRIP1 PUM2 LCK LYST KMT2C RASGRP1 ATF7IP OGA MYB	5.60e-08	194	168	9	66c056232ac216780acf4cc8ea325bd8ed1909c9
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	DENND2A BACH2 LAMA4 NCAM2 RYR2 IGSF10 HMCN1 NAV3 NEXN	5.85e-08	195	168	9	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	MYCN BACH2 PUM2 RASGRP1 PTPN13 ZFHX4 PDS5A PLCH1 MYBL2	6.97e-08	199	168	9	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A BACH2 LAMA4 NCAM2 RYR2 HMCN1 TENM3 NAV3 NEXN	7.27e-08	200	168	9	34f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EXTL3 ATL1 LIG3 SAMD11 PDS5A TLN2 PLCH1 PUS7L	2.56e-07	168	168	8	d69452e2cfeb74023b5cf3d09064d7dcad0008ec
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EZR DENND2A CCDC178 LYST SEMA6D HMCN1 MYO3B RIMBP2	5.78e-07	187	168	8	77886f99c229610abd28c4c370d2c7d1536c9782
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LAMA4 CCDC178 KLK3 DNAI3 FNDC1 PTPN13 THRB ZFHX4	6.02e-07	188	168	8	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL11A1 LAMA4 FNDC1 HMCN1 ZFHX4 NALCN NAV3 TLN2	7.05e-07	192	168	8	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	DENND2A BACH2 SLC24A3 RYR2 HMCN1 NALCN NAV3 TLN2	7.34e-07	193	168	8	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL11A1 LAMA4 SLC24A3 FNDC1 ZFHX4 TENM3 NALCN NEXN	7.93e-07	195	168	8	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL11A1 LAMA4 SLC24A3 FNDC1 ZFHX4 TENM3 NALCN NEXN	7.93e-07	195	168	8	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	DENND2A BACH2 LAMA4 NCAM2 RYR2 HMCN1 NAV3 NEXN	7.93e-07	195	168	8	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DENND2A LAMA4 NCAM2 RYR2 IGSF10 HMCN1 NAV3 TLN2	8.24e-07	196	168	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	LAMA4 DNAI3 RYR2 IGSF10 TENM3 MACF1 LRRC7 NEXN	8.56e-07	197	168	8	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Control-Lymphoid-CD4_T_cells\|Control / Condition, Lineage and Cell class	BACH2 PRDX2 LCK UBASH3A RASGRP1 PTP4A3 PTPN13 MYBL1	8.56e-07	197	168	8	dad6479caac07c1536f2b3082a51d61ae08beca0
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 NCAM2 RYR2 IGSF10 HMCN1 NAV3 MACF1 NEXN	8.56e-07	197	168	8	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	nucseq-Mesenchymal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A LAMA4 NCAM2 RYR2 HMCN1 NAV3 MACF1 NEXN	8.89e-07	198	168	8	8f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DENND2A LAMA4 DNAI3 RYR2 IGSF10 TENM3 MACF1 NEXN	9.24e-07	199	168	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	DENND2A BACH2 LAMA4 NCAM2 RYR2 HMCN1 TENM3 NAV3	9.24e-07	199	168	8	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	LAMA4 NCAM2 RYR2 IGSF10 HMCN1 NAV3 MACF1 NEXN	9.59e-07	200	168	8	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	LAMA4 NCAM2 RYR2 IGSF10 HMCN1 NAV3 MACF1 NEXN	9.59e-07	200	168	8	a510deaada669e690329183e18df02870bd204b3
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A BACH2 LAMA4 NCAM2 RYR2 HMCN1 TENM3 NAV3	9.59e-07	200	168	8	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A BACH2 LAMA4 NCAM2 RYR2 HMCN1 TENM3 NAV3	9.59e-07	200	168	8	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LAMA4 NCAM2 RYR2 IGSF10 HMCN1 NAV3 MACF1 NEXN	9.59e-07	200	168	8	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	Severe-B_naive-1\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	BACH2 ZNF318 CR2 WASHC2A NSD3 MACF1 OGA	2.47e-06	159	168	7	2881b054bbeb479221ee3c38bbd9b0815b123579
ToppCell	normal_Lung-T/NK_cells-Exhausted_CD8+_T\|T/NK_cells / Location, Cell class and cell subclass	STARD13 EZR NCAM2 LCK LYST RHPN1 NAV3	3.56e-06	168	168	7	76b49463895cdef27c90f831c6246bcb92b9761b
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	STARD13 PDE1C BACH2 NCAM2 GRIK3 SEMA6D TENM3	3.56e-06	168	168	7	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM NCAM2 CCDC197 PTP4A3 HMCN1 ZFHX4 UNC80	3.56e-06	168	168	7	e40a3f85be7e9bb23bfbc1f9cb5e5fc54bb43863
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNM NCAM2 CCDC197 PTP4A3 HMCN1 ZFHX4 UNC80	3.56e-06	168	168	7	b1d6c35a5ae69c8638afd68c2be5bc9ce6fd2659
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYCN GABRG2 NEXMIF GRIK3 AK9 IQCN NALCN	3.70e-06	169	168	7	606aa4ff25380d9470ec116ca86cd20f8b19587a
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYCN GABRG2 NEXMIF GRIK3 AK9 IQCN NALCN	3.70e-06	169	168	7	052aae2af5446a0de071d5dda5381b0b9a0ed54d
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BACH2 ZNF318 CR2 LYN FGD6 MYBL1 MYBL2	4.32e-06	173	168	7	b7e0193fd4983cb38d1bee441f608f73ee8743b9
ToppCell	COVID-19-Heart-Neuronal\|Heart / Disease (COVID-19 only), tissue and cell type	STARD13 NCAM2 GRIK3 PTPN13 SEMA6D TENM3 PTPRJ	4.32e-06	173	168	7	6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7
ToppCell	NS-moderate-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PDE1C LAMA4 ZBED10P PTP4A3 MAB21L3 NAV3 RIMBP2	4.66e-06	175	168	7	a1e0a15c69211d6db2edeb101476f0f6e08b90c8
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)\|343B / Donor, Lineage, Cell class and subclass (all cells)	CMYA5 RYR2 SEMA6D HMCN1 TENM3 SAMD11 TLN2	5.02e-06	177	168	7	e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87
ToppCell	343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	CMYA5 RYR2 SEMA6D HMCN1 TENM3 SAMD11 TLN2	5.02e-06	177	168	7	43ba6f12c2fb32698a420bf799d46ac1b558f146
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A SYNM LAMA4 NCAM2 RYR2 FNDC1 PLAAT5	5.21e-06	178	168	7	8ec2a25dda96c9cc9c2904b6cb18f75a293f4969
ToppCell	cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_2\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A SYNM LAMA4 NCAM2 RYR2 FNDC1 PLAAT5	5.21e-06	178	168	7	6c91331196696e0cf239d105f458e3230659fa38
ToppCell	droplet-Lung-nan-21m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EZR BACH2 CR2 RASGRP1 PTP4A3 TXNDC5 CMAHP	5.61e-06	180	168	7	b673d11d764e275883fc5edbad97137a6549df6a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DENND2A IQCN LYST SEMA6D HMCN1 MYO3B RIMBP2	6.03e-06	182	168	7	a8cc56f32efe180e8fb5d69dbe606a794b3db700
ToppCell	facs-Marrow-T-cells-3m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 ZNF318 LCK CR2 RASGRP1 MACF1 CMAHP	6.47e-06	184	168	7	b12fb85a064f715a4f0ada1df8e422c359b573cf
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PDE1C OBSCN CMYA5 RYR2 NALCN NEXN GABRA4	6.47e-06	184	168	7	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DENND2A ATL1 FNDC1 ZFHX4 NALCN NEXN AHNAK2	6.71e-06	185	168	7	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD13 MAP1A SYNM GRIK3 FNDC1 ZNF35 ZFHX4	6.71e-06	185	168	7	ca69499ba8c39b7ed6717d05685d6f70066a77bd
ToppCell	facs-Marrow-T-cells-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BACH2 ZNF318 LCK CR2 RASGRP1 MACF1 CMAHP	6.71e-06	185	168	7	e1fd0a807def8c2127194108b1a30c6de7024292
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	FNDC3B HECTD4 SLC24A3 HMGCS2 THRB TENM3 SNTB1	6.71e-06	185	168	7	1d874608aa2062024323512f68889219471b2f00
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE1C SLC24A3 NR4A3 ZBED10P ZFP69 LYN ZNF583	6.95e-06	186	168	7	a558fd00053e7dd6216b01dc8e650c30cee451f1
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	HECTD4 EXTL3 KDM2B TLN2 RERE SNTB1 SMG6	6.95e-06	186	168	7	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE1C SLC24A3 NR4A3 ZBED10P ZFP69 LYN ZNF583	6.95e-06	186	168	7	75b1f342be5d6dbe0e7acd924a0ca75964f6bab0
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE1C SLC24A3 NR4A3 ZBED10P ZFP69 LYN ZNF583	6.95e-06	186	168	7	0c3d195077de7b4c354c127a26116438aef29244
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	HECTD4 EXTL3 KDM2B TLN2 RERE SNTB1 SMG6	6.95e-06	186	168	7	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	DENND2A LAMA4 RYR2 HMCN1 NALCN NAV3 TLN2	7.20e-06	187	168	7	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	Adult-Mesenchymal-pericyte_cell\|Adult / Lineage, Cell type, age group and donor	DENND2A SYNM OBSCN LAMA4 RYR2 PTP4A3 PLEKHG3	7.20e-06	187	168	7	62759efb660179402fb574ce5701c89a2e17bcfe
ToppCell	facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHL24 ZNF318 HMGCS2 CR2 PTPRJ MACF1 LYN	7.20e-06	187	168	7	b51af2824e65734f333b1325117f4a2e88b17c23
ToppCell	facs-Spleen-nan-3m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KLHL24 ZNF318 HMGCS2 CR2 PTPRJ MACF1 LYN	7.20e-06	187	168	7	3ca3954f45f167e98a230f2847f0582d74fcd32e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	STARD13 CCDC178 HMGCS2 RASGRP1 PTPN13 MYO3B RIMBP2	7.20e-06	187	168	7	f6217d0dd425eac76900b44a4e48f45475f3ac36
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LAMA4 NCAM2 CMYA5 IGSF10 THRB HMCN1 NEXN	7.71e-06	189	168	7	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	EZR BACH2 ZNF318 LYST ATF7IP LYN VCPKMT	7.71e-06	189	168	7	b13f315f617840eb5143a4e8a33a657c20365c21
ToppCell	RV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	KLHL24 PDE1C OBSCN CMYA5 RYR2 HOOK2 NEXN	7.71e-06	189	168	7	5e80c47f63980904c4c1ff02c201b67b456a0974
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	DENND2A LAMA4 NCAM2 RYR2 HMCN1 TENM3 NAV3	7.98e-06	190	168	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|World / Chamber and Cluster_Paper	KLHL24 PDE1C OBSCN CMYA5 RYR2 HOOK2 NEXN	7.98e-06	190	168	7	de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC24A3 RYR2 HMCN1 NALCN NAV3 LRRC7 NEXN	7.98e-06	190	168	7	562ee3b025c29edf07b8b344323edb49d82f1c7e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC24A3 RYR2 HMCN1 NALCN NAV3 LRRC7 NEXN	7.98e-06	190	168	7	f5fb989afabb49d64d91324570cd8c80a4b9e67d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA4 SLC24A3 FNDC1 TENM3 NALCN NAV3 NEXN	8.26e-06	191	168	7	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	LV-06._Ventricular_Cardiomyocyte_II\|LV / Chamber and Cluster_Paper	KLHL24 PDE1C OBSCN CMYA5 RYR2 HOOK2 NEXN	8.26e-06	191	168	7	25f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	LAMA4 NCAM2 IGSF10 FNDC1 HMCN1 ZFHX4 SAMD11	8.26e-06	191	168	7	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	LAMA4 NCAM2 IGSF10 FNDC1 HMCN1 ZFHX4 SAMD11	8.26e-06	191	168	7	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA4 SLC24A3 FNDC1 TENM3 NALCN NAV3 NEXN	8.26e-06	191	168	7	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	LAMA4 SLC24A3 NCAM2 RYR2 HMCN1 TENM3 MACF1	8.55e-06	192	168	7	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A COL11A1 SYNM OBSCN LAMA4 RYR2 FNDC1	9.14e-06	194	168	7	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature-Adult_Glia\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STARD13 NCAM2 GRIK3 SEMA6D HMCN1 ZFHX4 TENM3	9.14e-06	194	168	7	d429bb5e422a07bd92f0dc48cd51528e8b7d9a72
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal-Glial_mature\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STARD13 NCAM2 GRIK3 SEMA6D HMCN1 ZFHX4 TENM3	9.14e-06	194	168	7	408dfc7060095972a54ae37ae8105521df6fbbee
ToppCell	3'-Pediatric_IBD-SmallIntestine-Neuronal\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STARD13 NCAM2 GRIK3 SEMA6D HMCN1 ZFHX4 TENM3	9.14e-06	194	168	7	bffdf6db0bf3fb338e7bb0789ae7dcde1fce0094
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	DENND2A LAMA4 NCAM2 RYR2 HMCN1 TENM3 NAV3	9.46e-06	195	168	7	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 NCAM2 RYR2 IGSF10 HMCN1 MACF1 NEXN	9.46e-06	195	168	7	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 NCAM2 RYR2 IGSF10 HMCN1 MACF1 NEXN	9.46e-06	195	168	7	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DENND2A PDE1C SYNM LAMA4 RYR2 FNDC1 NEXN	9.78e-06	196	168	7	9830fb3da7a60f65ad463e9054bb77c06b025e4d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 NCAM2 RYR2 IGSF10 HMCN1 MACF1 NEXN	9.78e-06	196	168	7	9737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	COL11A1 LAMA4 FNDC1 ZFHX4 TENM3 SAMD11 ASXL3	9.78e-06	196	168	7	57df2a57b35be9851ac0b1e5731baa53052511f0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA4 SLC24A3 FNDC1 HMCN1 TENM3 NALCN NEXN	9.78e-06	196	168	7	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	Bronchial-NucSeq-Stromal-Schwann\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYCN PDE1C NCAM2 GRIK3 ZFHX4 TENM3 UNC80	9.78e-06	196	168	7	a90c76d9c57a4491b94a321ba541b792ec5d8e83
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LAMA4 SLC24A3 FNDC1 HMCN1 TENM3 NALCN NEXN	9.78e-06	196	168	7	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 NCAM2 RYR2 IGSF10 HMCN1 MACF1 NEXN	9.78e-06	196	168	7	cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DENND2A LAMA4 NCAM2 RYR2 HMCN1 NAV3 MACF1	9.78e-06	196	168	7	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYCN PDE1C NCAM2 GRIK3 ZFHX4 TENM3 UNC80	1.01e-05	197	168	7	4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMA4 NCAM2 RYR2 IGSF10 HMCN1 MACF1 NEXN	1.01e-05	197	168	7	13896ec65ccda0b928c91d41112dc01b480036b7
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	SLC24A3 NCAM2 RYR2 NEO1 HMCN1 TENM3 MACF1	1.01e-05	197	168	7	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
Disease	smoking status measurement, Cannabis use, schizophrenia	PHC2 RMI1 SEMA6D SMG6	1.87e-05	29	162	4	EFO_0006527, EFO_0007585, MONDO_0005090
Disease	platelet component distribution width	DENND2A NRIP1 U2SURP PRDX2 THRB FAR2 PLEKHG3 TLN1 MACF1 PDS5A CATSPERB HOOK2 LYN FGD6 MYB	1.93e-05	755	162	15	EFO_0007984
Disease	testosterone measurement	STARD13 EZR POLR1A MAP1A SLC24A3 ZNF318 IQCN ADAR RMI1 THRB ZNF394 SEMA6D HMCN1 ZFHX4 PTPRJ CLYBL MACF1 RIMBP2 TPH1	7.79e-05	1275	162	19	EFO_0004908
Disease	smoking behavior	PDE1C SLC24A3 PHC2 RMI1 SEMA6D CLYBL NAV3 RERE SMG6	1.19e-04	341	162	9	EFO_0004318
Disease	Cannabis use, age at onset	RYR2 RMI1 LRRC7	1.48e-04	19	162	3	EFO_0004847, EFO_0007585
Disease	obsolete_red blood cell distribution width	FNDC3B NRIP1 KLHL24 POLR1A U2SURP HECTD4 AK9 F8 NSD3 NEO1 THRB PUS1 KDM2B PDS5A HOOK2 LYN MYB BORA MYBL2	1.59e-04	1347	162	19	EFO_0005192
Disease	myeloid white cell count	NRIP1 COL11A1 BACH2 CANX HECTD4 LCT CBS RMI1 CSF3R PTPRJ TLN2 RERE LYN SMG6 TPH1	2.15e-04	937	162	15	EFO_0007988
Disease	Adenoid Cystic Carcinoma	MYCN SLC24A3 KMT2C MYB MYBL1	2.32e-04	100	162	5	C0010606
Disease	neurotic disorder	ZNF184 GRIK3 TENM3 ASXL3 RERE	2.43e-04	101	162	5	EFO_0004257
Disease	lung squamous cell carcinoma (is_implicated_in)	RAD52 PTPN13 PTPRJ	3.02e-04	24	162	3	DOID:3907 (is_implicated_in)
Disease	age at menarche	FNDC3B COL11A1 ETFDH SLC24A3 RMI1 THRB SEMA6D ZFHX4 CLYBL RERE UNC80	4.65e-04	594	162	11	EFO_0004703
Disease	mean reticulocyte volume	POLR1A NEXMIF BACH2 ZNF318 THRB PTPRJ ATF7IP PUS1 TLN2 HOOK2 LYN MYB BORA	4.90e-04	799	162	13	EFO_0010701
Disease	neuroticism measurement	PDE1C ZNF184 ETFDH POM121L2 GRIK3 PHF2 SEMA6D CSF3R TENM3 PTPRJ ASXL3 HOOK2 RERE CMAHP	5.14e-04	909	162	14	EFO_0007660
Disease	pulse pressure measurement	FNDC3B NRIP1 COL11A1 CLGN ETFDH SLC24A3 DELEC1 ZNF318 CCDC197 PHC2 NSD3 LIG3 FNDC1 ZFHX4 TLN2 CMAHP FGD6 SMG6	6.66e-04	1392	162	18	EFO_0005763
Disease	rheumatoid arthritis, celiac disease	BACH2 HECTD4 UBASH3A	7.85e-04	33	162	3	EFO_0000685, EFO_0001060
Disease	optic disc size measurement	DENND2A ARHGEF10 PLEKHG3 NAV3 MACF1 RERE	9.74e-04	205	162	6	EFO_0004832
Disease	hoarding disorder	TLK2 SEMA6D TLN2	1.02e-03	36	162	3	EFO_0803361
Disease	cysteine measurement	GRIK3 NAV3	1.05e-03	9	162	2	EFO_0021000
Disease	lung carcinoma	RAD52 ZNF184 NR4A3 AK9 UBASH3A ADAR SEMA6D HIBCH CLYBL	1.44e-03	482	162	9	EFO_0001071
Disease	smoking behaviour measurement	PDE1C SLC24A3 RMI1 ZNF394 SEMA6D CLYBL	1.46e-03	222	162	6	EFO_0005671
Disease	kidney disease (implicated_via_orthology)	LCK LCT LYN	1.49e-03	41	162	3	DOID:557 (implicated_via_orthology)
Disease	DNA repair protein RAD51 homolog 4 measurement	TEX14 ZNF394	1.59e-03	11	162	2	EFO_0801531
Disease	hyperhomocysteinemia (implicated_via_orthology)	CBS F8	1.59e-03	11	162	2	DOID:9279 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	NEXMIF PHF2 KMT2C ASXL3	1.75e-03	93	162	4	C1535926
Disease	biological sex	RMI1 SEMA6D PTPRJ CLYBL LRRC7 TPH1	1.75e-03	230	162	6	PATO_0000047
Disease	fructose measurement, glucose measurement, galactose measurement	THRB FAR2	1.91e-03	12	162	2	EFO_0004468, EFO_0010477, EFO_0010481
Disease	interleukin 17 measurement	EXTL3 PTPRJ NAV3	1.95e-03	45	162	3	EFO_0008174
Disease	alcohol use disorder measurement, alcohol consumption measurement	SEMA6D PTPRJ PLCH1 GABRA4	2.04e-03	97	162	4	EFO_0007878, EFO_0009458
Disease	Genetic chronic primary adrenal insufficiency	BACH2 UBASH3A	2.25e-03	13	162	2	Orphanet_101960
Disease	lung adenocarcinoma (is_implicated_in)	KMT2C PTPN13 PTPRJ	2.49e-03	49	162	3	DOID:3910 (is_implicated_in)
Disease	depressive symptom measurement	ZNF184 POM121L2 GRIK3 PHF2 SEMA6D ASXL3 RERE CMAHP	2.53e-03	426	162	8	EFO_0007006
Disease	psychosis	SLC24A3 NALCN	2.61e-03	14	162	2	EFO_0005407
Disease	eating disorder, bipolar disorder	RYR2 NALCN	2.61e-03	14	162	2	EFO_0005203, MONDO_0004985
Disease	Asbestosis	PRDX2 ARG1	2.61e-03	14	162	2	C0003949
Disease	Pulmonary Fibrosis - from Asbestos Exposure	PRDX2 ARG1	2.61e-03	14	162	2	C2930617
Disease	eosinophil percentage of leukocytes	NRIP1 BACH2 NR4A3 DELEC1 RSPH6A UBASH3A CCDC197 RASGRP1 CSF3R RERE MYB	2.86e-03	746	162	11	EFO_0007991
Disease	mean corpuscular hemoglobin concentration	RAD52 FNDC3B POLR1A BACH2 HECTD4 ZNF318 NEO1 THRB PUS1 MACF1 HOOK2 CMAHP MYB BORA	3.20e-03	1105	162	14	EFO_0004528
Disease	FEV/FEC ratio	STARD13 FNDC3B PDE1C BACH2 U2SURP ZNF184 SLC24A3 RSPH6A PHF2 HMCN1 GSTCD FGD6 NEXN CNTN2 SMG6	3.24e-03	1228	162	15	EFO_0004713
Disease	myocardial infarction	FNDC3B HECTD4 RSPH6A TENM3 FGD6 YTHDF3 SMG6	3.31e-03	350	162	7	EFO_0000612
Disease	nervousness	ETFDH PTPRJ	3.42e-03	16	162	2	NCIT_C74532
Disease	sex interaction measurement, inflammatory bowel disease	UBASH3A RASGRP1 CMAHP	3.46e-03	55	162	3	EFO_0003767, EFO_0008343
Disease	HOMA-B	NCAM2 ARHGEF10 NAV3	3.46e-03	55	162	3	EFO_0004469
Disease	plasma beta-amyloid 1-40 measurement	STARD13 PDS5A	3.86e-03	17	162	2	EFO_0005659
Disease	Hypogammaglobulinemia	BACH2 CR2	3.86e-03	17	162	2	C0086438
Disease	Alzheimer disease, psychotic symptoms	TNRC6C RIMBP2	3.86e-03	17	162	2	EFO_0005940, MONDO_0004975
Disease	venous thromboembolism	RGSL1 NCAM2 DNAI3 F8 PTPRJ CATSPERB PLRG1 SMG6	4.03e-03	460	162	8	EFO_0004286
Disease	diastolic blood pressure, systolic blood pressure	FNDC3B CANX SLC24A3 RYR2 LIG3 RASGRP1 CLYBL TLN2 CMAHP NEXN	4.04e-03	670	162	10	EFO_0006335, EFO_0006336
Disease	open-angle glaucoma	FNDC3B COL11A1 ETFDH RERE SMG6	4.16e-03	191	162	5	EFO_0004190
Disease	HbA1c measurement	FNDC3B ETFDH TNRC6C CR2 RASGRP1 PTPRJ MACF1 HOOK2 CMAHP MYB	4.25e-03	675	162	10	EFO_0004541
Disease	migraine disorder, systolic blood pressure	SLC24A3 SMG6	4.33e-03	18	162	2	EFO_0006335, MONDO_0005277
Disease	Tourette syndrome, schizophrenia	NSD3 RERE	4.33e-03	18	162	2	EFO_0004895, MONDO_0005090
Disease	unipolar depression, response to bupropion, mood disorder	DELEC1 NAV3	4.82e-03	19	162	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	APOE carrier status, dementia	GRIK3 FAR2 CLYBL	4.85e-03	62	162	3	EFO_0007659, MONDO_0001627
Disease	loneliness measurement	PHF2 PTPRJ MACF1 RERE	4.93e-03	124	162	4	EFO_0007865
Disease	diet measurement, body mass index	CMYA5 FRA10AC1	5.33e-03	20	162	2	EFO_0004340, EFO_0008111
Disease	exercise test	RDX RYR2	5.33e-03	20	162	2	EFO_0004328

Protein segments in the cluster

Peptide	Gene	Start	Entry
VPDLKELLPSVKVWS	SMG6	1016	Q86US8
KDLSEPVPKGLWVGA	BACH2	456	Q9BYV9
GEALVWTKPVKDPKS	BBS4	431	Q96RK4
AKSLPVSVPVWGFKE	AKT1S1	181	Q96B36
PDGSWDSEPQKVIKL	ARHGEF10	1051	O15013
WTPGDVIPESEISKL	CATSPERB	161	Q9H7T0
GQKETLPSIWDSPTK	ALG5	51	Q9Y673
VVDWASGVSPKPDPK	RASGRP1	451	O95267
GSRKWPGIKPTEVTI	CCDC180	1611	Q9P1Z9
VSKPWVSLGSEKEIE	DNAI3	156	Q8IWG1
VLEKIPEGCTGWEEP	CCDC197	56	Q8NCU1
LKWTKAEDIDIETPG	ASXL3	241	Q9C0F0
ELKGKIPDVPGFSWV	ARG1	151	P05089
PSPEKIKWAEELIAA	CLYBL	286	Q8N0X4
KWEVPLPKVRAQGET	NSA2	116	O95478
EKNGKLWSPDEEVSP	PDS5A	816	Q29RF7
LWSPDEEVSPEVLAK	PDS5A	821	Q29RF7
KWAVTPDAGDGVVKP	RAD52	331	P43351
APSWTKVAEEGDKPP	IQCN	631	Q9H0B3
GELLPTKKFWEPDDS	PUM2	16	Q8TB72
SPKWKPADLKEVTEE	HIBCH	356	Q6NVY1
FTVKVTGEPKPEITW	NEXN	601	Q0ZGT2
DDKLTPKIGFPWSEI	RDX	231	P35241
PVEPKKIIDSLEWLD	FAR2	171	Q96K12
AKVLKWGEEIEGFPS	VCPKMT	121	Q9H867
DCEVVPKEPALVLKW	PTPRJ	726	Q12913
SDISPKGVWDKILEP	KMT2C	4626	Q8NEZ4
PGPALEDIAIKWEDK	MAP1A	1331	P78559
KWPVAPKEITVEDSF	LRRC7	616	Q96NW7
GISEDPGPNWKLKVS	HOOK2	56	Q96ED9
DWSVTTPVKEVKPGE	CCDC178	136	Q5BJE1
EGVRISSWPKEKPGS	COL11A1	1656	P12107
AVPLAKTDTWPKDVG	HMGCS2	41	P54868
ESELWKGPLPETDEK	FRA10AC1	286	Q70Z53
WTEPPKCIEGQEKVA	F13B	321	P05160
TEETHPVSWKPEIIK	PLRG1	496	O43660
HLSPDKKWLGTPIEE	PARG	446	Q86W56
PPAVIEALKDVDKWS	PDE1C	156	Q14123
WKTVSSGLPEDPEKA	NAV3	961	Q8IVL0
TFPSEVPSKAKVVWE	LCT	871	P09848
PSEKGPIKWVITDAE	NRIP1	1036	P48552
AREGAKFPIKWTAPE	LCK	396	P06239
IYTWTKGPEKSVEVP	GABRA4	201	P48169
KWTVTVEDGPTKSDP	F8	531	P00451
LNPELIKGPWTKEED	MYB	86	P10242
FIVPDPKKAAVWEIT	LIG3	771	P49916
KIPAPWAAGKTVETV	HECTD4	626	Q9Y4D8
WKPGSDTIKPNVDDS	PRDX2	176	P32119
TPFDTPSGKLETVKW	SLC24A3	436	Q9HC58
ELVPAVEIPTTWSKK	MAB21L3	186	Q8N8X9
KWLKETEGSIPPTET	MACF1	4341	Q9UPN3
VADGIPTPAINWKKD	HMCN1	4191	Q96RW7
VTGEPKPETVWKKDG	OBSCN	261	Q5VST9
VSKPVWDFLSKETPA	DTX3	21	Q8N9I9
WKEKGAPLNTPVTED	ETFDH	131	Q16134
TQATKVKEEPSVWPG	FBH1	421	Q8NFZ0
VKEEPSVWPGKKTIQ	FBH1	426	Q8NFZ0
LDCEVTGDPKPKIFW	IGSF10	2161	Q6WRI0
SLAITGVPVVTWPKK	KDM2B	561	Q8NHM5
DPVTGEWKSLAKLPE	KLHL24	336	Q6TFL4
WSSEEEEPVKKAGPV	ATL1	21	Q8WXF7
PECREKWEGFPKVSI	BFAR	71	Q9NZS9
ELKSDGPIWKHATPV	CABIN1	1111	Q9Y6J0
ITKDKVDGTWDKPAP	CR2	66	P20023
QKEAGTPPLWKIAVS	ADAR	186	P55265
SEWEGKKEVPTPAPS	DENND2A	51	Q9ULE3
LEAGKWKSIVPAPGE	DELEC1	6	Q9P2X7
VKWDPPKDNGGSEIL	FNDC3B	591	Q53EP0
GKEDLLSSSVPKWPS	FNDC1	1191	Q4ZHG4
KVVVVWNSPKLPSED	EXTL3	691	O43909
KDVIVPSPWTDHEGK	BORA	106	Q6PGQ7
SIEDKVKEVFPPWRG	CMYA5	291	Q8N3K9
GAPDASFPTWKEVVK	CRYBG2	536	Q8N1P7
SNKTWVLTPKVPEGD	GABRG2	51	P18507
KIPDEEATKPEGWLD	CANX	311	P27824
GSPEDKEAKEPLWIR	CBS	31	P35520
KEGEEVKTGVTSFPW	CATIP	151	Q7Z7H3
EPRVAPTKVWAKGVS	CNTN2	811	Q02246
EWEDDLPKPKTTEVI	BNIP2	96	Q12982
LTVLEEDEKKPVPWE	CSF3R	696	Q99062
PEGSKAEWKETPCIL	ATF7IP	81	Q6VMQ6
PLVWKIPVQEEKATD	LYST	81	Q99698
EGAKFPIKWTAPEAI	LYN	401	P07948
DDKLTPKIGFPWSEI	EZR	231	P15311
SLKEDGLEKVGVWSP	GRIK3	396	Q13003
GVWKVLFKPPTSDAE	PNMA1	86	Q8ND90
GEPEVPESAFWKKII	RYR2	4471	Q92736
DWNVLPAAVSPKEGK	GSTCD	401	Q8NEC7
LNPELIKGPWTKEED	MYBL1	81	P10243
VDPDLKLTKVAPEGW	PTPN13	626	Q12923
EESLPPTEATWKIKG	LAMA4	1576	Q16363
WAEKIPGFTDLPKED	NR4A3	451	Q92570
EEKAVDIVPKSVWKP	RSPH6A	396	Q9H0K4
WDPVKLSEGETIKPV	AK9	1351	Q5TCS8
IKQLAKSVIVGWEPP	RIMBP2	306	O15034
SGDVIPWIPKAQKEI	RGSL1	461	A5PLK6
KLWKASVEVEAPPSV	STARD13	951	Q9Y3M8
VKKGSPVSEIGWETP	SNTB1	201	Q13884
PVPVKQKDSSEATGW	TNRC6C	696	Q9HCJ0
ITGKAWVKETPRSVP	POLR1A	711	O95602
TDDIPWKGLDGSVVK	TEX14	451	Q8IWB6
VEPPDIVKKLSWVEN	PHF2	206	O75151
EEVEDVSPGPWGLVK	SYNM	771	O15061
EVLWTGPKVVSKEIP	OGA	246	O60502
EKWLSKTELIGLPPE	PUS7L	146	Q9H0K6
VTAEAQVTPKPWEAK	RMI1	116	Q9H9A7
WEKVAPERDGKSPTV	PLEKHG3	951	A1L390
RSWGTEKVDVPKAPG	PUS1	316	Q9Y606
VLNPDLVKGPWTKEE	MYBL2	76	P10244
GVPGPLDSVEKIKWD	NEXMIF	1101	Q5QGS0
LTKEPVLWTLVSKEP	PNPLA5	256	Q7Z6Z6
ECEVTGKPTPTVKWV	NEO1	361	Q92859
KFPLPKTIWDGEETV	SIX5	191	Q8N196
VSWEKAGPEEAKAPV	SH3TC1	41	Q8TE82
GEEAPAPEDVTKWTV	SAMD11	531	Q96NU1
DALQALKVGEKPPTW	SPATA31E1	1031	Q6ZUB1
LKVGEKPPTWEVTLG	SPATA31E1	1036	Q6ZUB1
KPVPKLIEKCWTEDE	RERE	386	Q9P2R6
PLGLKETKELDWSTP	RHPN1	111	Q8TCX5
VPETWIDGPKDTSVE	MRPL24	166	Q96A35
SVSFETPEWPIKKEK	POM121L2	276	Q96KW2
EPIFKVAPSKWEAVD	U2SURP	751	O15042
VGKEPPKISNKVDVW	TLK2	651	Q86UE8
EDKTEKWSSQPEGPL	AHNAK2	5341	Q8IVF2
IIEPPEGTKIYKDSW	CMAHP	316	Q9Y471
SSVVKPAGWLDDEPK	CLGN	306	O14967
KLNPEWFDVKPTVGE	SPATA4	226	Q8NEY3
TLKEDGMETVPWFPK	TPH1	96	P17752
IPKVEFTEEEIKTWG	TPH1	161	P17752
LAPWGPVKVKKEEEE	ZNF35	11	P13682
IGTWDEKGSVVKAPP	YTHDF3	276	Q7Z739
DWKEVAPGEKSVPET	PHC2	471	Q8IXK0
EEQKPTKEPLEVSEW	ZFHX4	1301	Q86UP3
KFPTWETTKPELELL	USP27X	46	A6NNY8
LLPVKVEEDSPGSWE	ZNF394	36	Q53GI3
KPDVVSLLEQGKEPW	ZNF565	91	Q8N9K5
PPGKVVEDWLSLVKA	PTP4A3	76	O75365
EASKPKDVDLTLPGW	UTP14C	616	Q5TAP6
KKEGSPWSASEPSIE	UNC80	1426	Q8N2C7
DSTPPGEDIWKKFEL	MYCN	41	P04198
VCDAEGEPIPEITWK	NCAM2	321	O15394
KGTEWVDPEDPTVIA	TLN1	2291	Q9Y490
KSIGHKPEPTDEEWE	THRB	206	P10828
KPEPTDEEWELIKTV	THRB	211	P10828
KEEVSPLGSKAPIWI	FGD6	1206	Q6ZV73
FKGKIEAILPWGPTD	ZBED10P	81	Q96FA7
ERAPGDPKWLDVIEK	TBC1D10B	391	Q4KMP7
TPDIEIWKRIGKDPA	TENM3	2366	Q9P273
PWKPKEAVEENGVIT	PBK	211	Q96KB5
EEPPPVKIAWKTAAA	NSD3	461	Q9BZ95
PKSPTKGEDWETLKS	PLCH1	1316	Q4KWH8
KPDVISFLEQGKEPW	ZNF582	51	Q96NG8
VISKLEKGEEPWSLE	ZNF658	56	Q5TYW1
KKWPEVLLSPEAVAA	RELT	301	Q969Z4
KEKGIWKPETPQDSS	WASHC2A	926	Q641Q2
KPDVISSLEQGKEPW	ZFP82	51	Q8N141
KPDVVSLLEQGKEPW	ZNF140	51	P52738
MKGTEWVDPEDPTVI	TLN2	2291	Q9Y4G6
GPAQEEPWEKKESLG	ZNF232	146	Q9UNY5
LAPTWEELSKKEFPG	TXNDC5	356	Q8NBS9
DWSSIPKPENEGKLI	PLAAT5	106	Q96KN8
EPWIPDLLGSKEKEL	ZSCAN29	191	Q8IWY8
DSVWTAVPEDKVPKP	SEMA6D	351	Q8NFY4
VPVPEKQISWEDKKA	WDR87	2406	Q6ZQQ6
PETWESPEKPKTEAL	ZNF318	1966	Q5VUA4
KPDVISLLEQGKEPW	ZNF583	51	Q96ND8
VTEKTIPSWEKGPVN	ZNF184	166	Q99676
KPAVISSLEQGKEPW	ZNF461	51	Q8TAF7
EGKWELVNPPVKTLT	UBASH3A	631	P57075
KPSVISQLEKGEEPW	ZFP69	121	Q49AA0
GWGSIEPEEFLTPKK	KLK3	156	P07288
LLSVKWDVEDPVTVP	NALCN	1226	Q8IZF0
PDPTDTWEIIETIGK	MYO3B	21	Q8WXR4